2nd Circ. Reverses NYU's $3.5M Award In Drug License Spat
The Second Circuit on Wednesday reversed a $3.5 million summary judgment in favor of New York University in a breach of contract dispute between the school and drugmaker Galderma Laboratories, finding...To view the full article, register now.
Already a subscriber? Click here to view full article